Table 3.
Relative frequency of individuals reporting use of medications for noncommunicable diseases (NCDs) related to obesity, by BMI classification (n = 59,402).
| BMI classificationa | Hypertension | DM | CVD | Stroke | CKD | Lung disease | Arthritis or rheumatism | Chronic back problem | Depression | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Individuals reporting use of medications, by group of NCDs related to obesity | ||||||||||||||||||
| % | 95%CI | % | 95%CI | % | 95%CI | % | 95%CI | % | 95%CI | % | 95%CI | % | 95%CI | % | 95%CI | % | 95%CI | |
| Underweight | 6.9 | 4.8–8.9 | 2.6 | 2.3–2.9 | 2.0 | 1.7–2.3 | 0.6 | 0.5–0.8 | 0.7 | 0.5–0.9 | 0.6 | 0.5–0.8 | 2.2 | 1.8–2.5 | 5.8 | 5.3–6.4 | 3.0 | 2.6–3.4 |
| Normal weight | 10.2 | 9.6–10.9 | 1.5 | 0.7–2.2 | 1.6 | 0.4–3.7 | 0.2 | 0.0–0.4 | 0.5 | 0.0–0.9 | 1.5 | 0.5–2.5 | 1.4 | 0.5–2.3 | 4.8 | 3.0–6.5 | 3.1 | 1.6–4.7 |
| Overweight | 18.6 | 17.7–19.4 | 5.2 | 4.6–5.7 | 2.8 | 2.4–3.2 | 0.8 | 0.6–1.0 | 0.9 | 0.7–1.1 | 0.7 | 0.5–0.9 | 3.9 | 3.0–3.8 | 8.2 | 7.6–8.9 | 4.1 | 3.6–4.7 |
| Obesity I | 28.4 | 26.7–30.1 | 7.8 | 6.8–8.8 | 3.2 | 2.7–3.8 | 1.4 | 0.9–1.9 | 1.1 | 0.7–1.4 | 1.1 | 0.6–1.6 | 4.7 | 4.0–5.4 | 8.8 | 7.8–9.7 | 5.5 | 4.6–6.4 |
| Obesity II | 35.1 | 32.0–38.2 | 9.9 | 8.0–11.8 | 4.5 | 3.2–5.9 | 0.8 | 0.4–1.2 | 0.5 | 0.0–1.0 | 1.2 | 0.4–2.0 | 5.6 | 4.2–7.1 | 10.8 | 8.7–12.9 | 6.5 | 4.7–8.4 |
| Obesity III | 41.8 | 36.2–47.5 | 9.1 | 6.5–11.7 | 2.9 | 1.4–4.4 | 0.9 | 0.1–1.9 | 1.2 | 0.4–1.9 | 1.3 | 0.4–2.3 | 7.6 | 4.6–10.6 | 10.4 | 7.3–13.6 | 6.9 | 4.4–9.5 |
National Health Survey, Brazil, 2013.
aUnderweight: BMI < 18.5 kg/m2. Normal weight: BMI 18.5–24.9 kg/m2. Overweight: BMI 25.0–29.9 kg/m2. Obesity I: BMI 30.0–34.5 kg/m2. Obesity II: BMI 35.0–39.9 kg/m2. Obesity III: BMI ≥ 40 kg/m2.